SCHEMBL26217680

SCHEMBL26217680

CCCC(CCC)c1cccc(C(C)Cc2ccccc2F)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 3/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A3 Q01959 3/20 0.36
KCNH2 Q12809 2/20 0.36
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TP53 P04637 2/20 0.32
MAP4K4 O95819 1/20 0.32
HPGD P15428 1/20 0.31
TAAR1 Q96RJ0 3/20 0.31
ALOX5AP P20292 1/20 0.31
HTR2C P28335 1/20 0.31
EED O75530 1/20 0.31
POLB P06746 1/20 0.30
HTT P42858 2/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14402586 0.72 TAAR1 (0.41) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL26304397 0.72 HRH1 (0.35) CYP2D6KCNH2MAPT
SCHEMBL25482991 0.70 TAAR1 (0.42) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL13849907 0.67 TAS1R3 (0.40) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL23352304 0.67 TAAR1 (0.39) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL14402510 0.67 TAS1R3 (0.40) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL22984964 0.67 TSHR (0.38) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL19003563 0.67 HTT (0.42) MEN1KMT2AMAP4K4HTT
SCHEMBL139640 0.66 GABRA1 (0.52) SLC6A4CYP3A4CYP2D6SLC6A2SLC6A3
SCHEMBL23717412 0.65 ADRB1 (0.50) TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4242202-A1 BENZIMIDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) 2023-09-13 EP disclosed